-
Global Biotechnology & Pharmaceutical Markets2 months agoDrugmakers cherry pick launch regions as MFN creates ‘policy environment like an earthquake’
With multiple drug pricing initiatives like Most Favored Nation now in force, drugmakers have to reinvent their commercial strategies to stay ahead of the fast-moving policy...
-
Global Biotechnology & Pharmaceutical Markets2 months agoWebinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets
Watch this discussion on how GLP-1 drugs for obesity are changing the shape of U.S. healthcare. From direct-to-consumer portals to pharmacy deals, how these drugs reach...
-
Global Biotechnology & Pharmaceutical Markets2 months agoSolstice rises with $225M to develop next-gen CTLA-4 drug from China
Solstice Oncology, founded in February, is emerging from stealth having already secured an investigational new drug application from the FDA for a Phase 2 trial of...
-
Global Biotechnology & Pharmaceutical Markets2 months agoBeyond China: Five other overseas destinations for biopharma dollars
As geopolitical tensions between the U.S. and China grow increasingly complicated, here are five alternative territories for biotech investments.
-
Global Biotechnology & Pharmaceutical Markets2 months agoDrug pricing policy ‘earthquake’ forcing rethink of global commercialization plans: survey
Shifts in drug pricing and market access policies around the world have caused an “earthquake” that will reverberate for years to come, a survey of industry...
-
Global Biotechnology & Pharmaceutical Markets2 months agoDHCR24 controls endothelial cell aging via the SPHK2/SPNS2-S1P pathway
Scientists in China have uncovered a previously hidden molecular pathway that connects cholesterol metabolism to the aging of blood vessels, a discovery that could reshape how...
-
Global Biotechnology & Pharmaceutical Markets2 months agoGut Microbiota Metabolites Show Promise Against Disc Degeneration
In a discovery that could reshape how scientists think about back pain, researchers in China have mapped, molecule by molecule, how metabolites produced by the trillions...
-
Global Biotechnology & Pharmaceutical Markets2 months agoUK’s Claret Capital raises €575m for European biotechs
London-based Claret Capital Partners has closed its fourth European Growth Capital Fund, raising €575m for "Europe's boldest innovators."
-
Global Biotechnology & Pharmaceutical Markets2 months agoTurning sorghum stalk lignocellulose into valuable xylooligosaccharides efficiently
Researchers in India have developed a process that transforms sorghum stalks, an agricultural residue often discarded after grain harvest, into high-value prebiotic xylooligosaccharides with performance that...
-
Global Biotechnology & Pharmaceutical Markets2 months agoGut microbial metabolites shape Fusobacterium growth and colorectal cancer behavior
In a striking demonstration of how the chemical environment of the gut can dictate the fate of both microbes and tumors, researchers in India have shown...
Genmab’s cancer bispecific delivers early survival win in ‘exceedingly positive’ Phase 3 readout
Genmab’s cancer bispecific delivers early OS win in ‘exceedingly positive’ Phase 3 readout
STAT+: HHS moves to allow compounding of some unapproved peptides
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
